BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32353108)

  • 21. Human Amniotic Mesenchymal Stem Cells Alleviate aGVHD after allo-HSCT by Regulating Interactions between Gut Microbiota and Intestinal Immunity.
    Bu X; Wang J; Yin Z; Pan W; Liu L; Jin H; Liu Q; Zheng L; Sun H; Gao Y; Ping B
    Stem Cell Rev Rep; 2023 Jul; 19(5):1370-1383. PubMed ID: 36870009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation.
    Yoshifuji K; Inamoto K; Kiridoshi Y; Takeshita K; Sasajima S; Shiraishi Y; Yamashita Y; Nisaka Y; Ogura Y; Takeuchi R; Toya T; Igarashi A; Najima Y; Doki N; Kobayashi T; Ohashi K; Suda W; Atarashi K; Shiota A; Hattori M; Honda K; Kakihana K
    Blood Adv; 2020 Oct; 4(19):4607-4617. PubMed ID: 32991720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children.
    Masetti R; Leardini D; Muratore E; Fabbrini M; D'Amico F; Zama D; Baccelli F; Gottardi F; Belotti T; Ussowicz M; Fraczkiewicz J; Cesaro S; Zecca M; Merli P; Candela M; Pession A; Locatelli F; Prete A; Brigidi P; Turroni S
    Blood; 2023 Oct; 142(16):1387-1398. PubMed ID: 37856089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between histopathological alterations and diarrhea severity in acute intestinal graft-versus-host disease.
    da Costa LNG; Costa-Lima C; de Meirelles LR; Carvalho RB; Colella MP; Aranha FJP; Vigorito AC; De Paula EV
    Medicine (Baltimore); 2018 May; 97(19):e0600. PubMed ID: 29742694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.
    Doki N; Suyama M; Sasajima S; Ota J; Igarashi A; Mimura I; Morita H; Fujioka Y; Sugiyama D; Nishikawa H; Shimazu Y; Suda W; Takeshita K; Atarashi K; Hattori M; Sato E; Watakabe-Inamoto K; Yoshioka K; Najima Y; Kobayashi T; Kakihana K; Takahashi N; Sakamaki H; Honda K; Ohashi K
    Ann Hematol; 2017 Sep; 96(9):1517-1523. PubMed ID: 28733895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Amniotic Membrane-Derived Mesenchymal Stem Cells Prevent Acute Graft-Versus-Host Disease in an Intestinal Microbiome-Dependent Manner.
    Bu X; Gao Y; Pan W; Liu L; Wang J; Yin Z; Ping B
    Transplant Cell Ther; 2024 Feb; 30(2):189.e1-189.e13. PubMed ID: 37939900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease.
    Chen Y; Zhao Y; Cheng Q; Wu D; Liu H
    J Immunol Res; 2015; 2015():145859. PubMed ID: 26090477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota trajectory in β-thalassemia major children who underwent allogeneic hematopoietic stem cell transplantation.
    Luo H; Liu T; Qu Y; Kuang C; Xiao M; Sun J; Chen H; Wu J; Liu X; Jiang H
    Transpl Infect Dis; 2023 Oct; 25(5):e14111. PubMed ID: 37615262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome.
    Zargari Marandi R; Jørgensen M; Ilett EE; Nørgaard JC; Noguera-Julian M; Paredes R; Lundgren JD; Sengeløv H; MacPherson CR
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance.
    Hong T; Wang R; Wang X; Yang S; Wang W; Gao Q; Zhang X
    Front Immunol; 2021; 12():644982. PubMed ID: 33815399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
    Parco S; Benericetti G; Vascotto F; Palmisciano G
    Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decline of serum albumin precedes severe acute GVHD after haploidentical HSCT.
    Takahashi N; Mochizuki K; Sano H; Kobayashi S; Ohara Y; Ikeda K; Ohto H; Kikuta A
    Pediatr Int; 2021 Sep; 63(9):1048-1054. PubMed ID: 33253440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease.
    Zeng K; Brewster R; Kang JB; Tkachenko E; Brooks E; Bhatt AS; Fodor AA; Andermann TM
    Transplant Cell Ther; 2024 Feb; 30(2):237.e1-237.e9. PubMed ID: 37944820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease.
    Broglie L; Rademaker A; Galvin J; Ray A; Tse WT; Duerst R; Schneiderman J; Kletzel M; Chaudhury S
    Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):169-174. PubMed ID: 29397331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment.
    Shang T; Guo Y; Li XR; Zhou Z; Qi Y; Salahdiin K; Shen R; He S; Wang M; Shi ZX; Zhao X; Yang J; Fan G; Wang Y; Gao X; Zhu Y; Feng Y
    Biomed Pharmacother; 2022 Apr; 148():112675. PubMed ID: 35183993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
    Faraci M; Bonaretti C; Dell'Orso G; Pierri F; Giardino S; Angiero F; Blasi S; Farronato G; Di Marco E; Trevisiol A; Olcese E; Rufino L; Squillario M; Biassoni R
    Sci Rep; 2024 Mar; 14(1):6708. PubMed ID: 38509104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A comparison of clinical characteristics and prognosis of adult acute graft-versus-host disease between human leukocyte antigen- identical and -mismatched allogeneic hematopoietic stem cell transplantation].
    Zhao X; Xu L; Liu D; Han T; Wang Y; Zhang X; Yan C; Chen H; Han W; Wang J; Zhao T; Li Y; Zhang B; Zhao X; Liu K; Huang X
    Zhonghua Nei Ke Za Zhi; 2014 Jan; 53(1):35-9. PubMed ID: 24674726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disturbances in microbial skin recolonization and cutaneous immune response following allogeneic stem cell transfer.
    Bayer N; Hausmann B; Pandey RV; Deckert F; Gail LM; Strobl J; Pjevac P; Krall C; Unterluggauer L; Redl A; Bachmayr V; Kleissl L; Nehr M; Kirkegaard R; Makristathis A; Watzenboeck ML; Nica R; Staud C; Hammerl L; Wohlfarth P; Ecker RC; Knapp S; Rabitsch W; Berry D; Stary G
    Leukemia; 2022 Nov; 36(11):2705-2714. PubMed ID: 36224329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged Suppression of Butyrate-Producing Bacteria Is Associated With Acute Gastrointestinal Graft-vs-Host Disease and Transplantation-Related Mortality After Allogeneic Stem Cell Transplantation.
    Meedt E; Hiergeist A; Gessner A; Dettmer K; Liebisch G; Ghimire S; Poeck H; Edinger M; Wolff D; Herr W; Holler E; Weber D
    Clin Infect Dis; 2022 Mar; 74(4):614-621. PubMed ID: 34043764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.